Modest effect on plaque progression and vasodilatory function in atherosclerosis-prone mice exposed to nanosized TiO(2)

Part Fibre Toxicol. 2011 Nov 10:8:32. doi: 10.1186/1743-8977-8-32.

Abstract

Background: There is growing evidence that exposure to small size particulate matter increases the risk of developing cardiovascular disease.

Methods: We investigated plaque progression and vasodilatory function in apolipoprotein E knockout (ApoE(-/-)) mice exposed to TiO(2). ApoE(-/-) mice were intratracheally instilled (0.5 mg/kg bodyweight) with rutile fine TiO2 (fTiO2, 288 nm), photocatalytic 92/8 anatase/rutile TiO(2) (pTiO(2), 12 nm), or rutile nano TiO(2) (nTiO(2), 21.6 nm) at 26 and 2 hours before measurement of vasodilatory function in aorta segments mounted in myographs. The progression of atherosclerotic plaques in aorta was assessed in mice exposed to nanosized TiO(2) (0.5 mg/kg bodyweight) once a week for 4 weeks. We measured mRNA levels of Mcp-1, Mip-2, Vcam-1, Icam-1 and Vegf in lung tissue to assess pulmonary inflammation and vascular function. TiO(2)-induced alterations in nitric oxide (NO) production were assessed in human umbilical vein endothelial cells (HUVECs).

Results: The exposure to nTiO(2) was associated with a modest increase in plaque progression in aorta, whereas there were unaltered vasodilatory function and expression levels of Mcp-1, Mip-2, Vcam-1, Icam-1 and Vegf in lung tissue. The ApoE(-/-) mice exposed to fine and photocatalytic TiO(2) had unaltered vasodilatory function and lung tissue inflammatory gene expression. The unaltered NO-dependent vasodilatory function was supported by observations in HUVECs where the NO production was only increased by exposure to nTiO(2).

Conclusion: Repeated exposure to nanosized TiO(2) particles was associated with modest plaque progression in ApoE(-/-) mice. There were no associations between the pulmonary TiO(2) exposure and inflammation or vasodilatory dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Air Pollutants / pharmacokinetics
  • Air Pollutants / toxicity*
  • Animals
  • Aorta / drug effects
  • Aorta / pathology
  • Aorta / physiopathology
  • Atherosclerosis / chemically induced*
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology
  • Cell Adhesion Molecules / genetics
  • Cell Adhesion Molecules / metabolism
  • Cells, Cultured
  • Chemokines / genetics
  • Chemokines / metabolism
  • Disease Models, Animal
  • Disease Progression
  • Gene Expression / drug effects
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Intubation, Intratracheal
  • Lung / drug effects
  • Lung / metabolism
  • Mice
  • Mice, Knockout
  • Nanoparticles / administration & dosage
  • Nanoparticles / toxicity*
  • Titanium / pharmacokinetics
  • Titanium / toxicity*
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • Vasodilation / drug effects
  • Vasodilation / physiology

Substances

  • Air Pollutants
  • Cell Adhesion Molecules
  • Chemokines
  • Vascular Endothelial Growth Factor A
  • titanium dioxide
  • Titanium